Acceptability of intranasal live attenuated influenza vaccine; influenza knowledge and vaccine intent in The Gambia

被引:12
|
作者
Armitage, Edwin T. [1 ]
Camara, Janko [1 ]
Bah, Sulayman [1 ]
Forster, Alice S. [2 ]
Clarke, Ed [1 ]
Kampmann, Beate [1 ,3 ]
de Silva, Thushan I. [1 ,3 ]
机构
[1] Med Res Council Unit Gambia, Vaccines & Immun Theme, POB 273, Banjul, Gambia
[2] UCL, Res Dept Behav Sci & Hlth, Gower St, London WC1E 6BT, England
[3] Imperial Coll London, Dept Med, Ctr Int Child Hlth, Sect Paediat, St Marys Campus, London W2 1PG, England
基金
英国惠康基金; 英国医学研究理事会;
关键词
Influenza; Vaccine acceptability; Intranasal live attenuated influenza vaccine; Knowledge; attitudes and perceptions; Health Belief Model; The Gambia; HEALTH BELIEF MODEL; PARTICIPATORY WOMENS GROUPS; RANDOMIZED CONTROLLED-TRIAL; RURAL EASTERN INDIA; SEASONAL INFLUENZA; PREGNANT-WOMEN; SOUTH-AFRICA; ATTITUDES; IMMUNIZATION; PERCEPTIONS;
D O I
10.1016/j.vaccine.2018.02.037
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: The burden of influenza is increasingly recognised in Africa. The WHO recommends introducing influenza vaccination to high-risk groups: pregnant women, children <5 years, and the elderly. The Gambia currently has no influenza vaccination policy, but the NASIMMUNE study, a clinical trial of intranasal live attenuated influenza vaccines (LAIV) in young children provided an opportunity to study maternal attitudes towards LAW for the first time in sub-Saharan Africa. We assess acceptability of LAIV, influenza knowledge and attitudes towards influenza vaccination in Gambian women. Additionally, we investigate predictors of willingness to receive influenza vaccine (intent) in pregnancy or seasonally for children <5. Methods: A cross-sectional survey was conducted in Gambian women at two urban health facilities. To assess LAIV acceptability, the exposure group (women whose children had received LAIV during the NASIMMUNE study) were compared to a control group (women whose children were not enrolled in the NASIMMUNE study). Demographics and health belief constructs were analysed as predictors of influenza knowledge and vaccine intent. Findings: The exposure group (n = 150) expressed a higher preference for a nasal spray vaccine than an injection compared to the control group (n = 304) (93.3% vs. 34.9%, OR = 26.15, p < 0.0001). Those in the exposure group who preferred the nasal spray found it less distressing, safer or equally safe, and easier or equally easy to give (all p < 0.001) than injections. Influenza knowledge increased with education level (p = 0.006 for higher education vs. none), and varied between sites (p = 0.0005). Vaccine intent was >98%, but no association with influenza knowledge or difference between groups was observed. Various health belief constructs were associated with vaccine intent. Conclusion: LAIV acceptability was higher in those with first-hand experience. Influenza vaccine intent was also high. Incorporation of seasonal LAIV into the childhood immunisation schedule in The Gambia would be feasible, particularly if combined with community-based health education. (C) 2018 The Authors. Published by Elsevier Ltd.
引用
收藏
页码:1772 / 1780
页数:9
相关论文
共 50 条
  • [1] Acceptability of live attenuated influenza vaccine by vaccine providers in Quebec, Canada
    Dube, Eve
    Gagnon, Dominique
    Kiely, Marilou
    Boulianne, Nicole
    Landry, Monique
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (04) : 956 - 960
  • [2] Live attenuated intranasal influenza vaccine
    Esposito, Susanna
    Montinaro, Valentina
    Groppali, Elena
    Tenconi, Rossana
    Semino, Margherita
    Principi, Nicola
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2012, 8 (01) : 76 - 80
  • [3] Localized Mucosal Response to Intranasal Live Attenuated Influenza Vaccine in Adults
    Barria, Maria Ines
    Garrido, Jose Luis
    Stein, Cheryl
    Scher, Erica
    Ge, Yongchao
    Engel, Stephanie M.
    Kraus, Thomas A.
    Banach, David
    Moran, Thomas M.
    JOURNAL OF INFECTIOUS DISEASES, 2013, 207 (01) : 115 - 124
  • [6] History of Live, Attenuated Influenza Vaccine
    Treanor, John
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2020, 9 : S3 - S9
  • [8] Cost Effectiveness of Influenza Vaccine for US Children Live Attenuated and Inactivated Influenza Vaccine
    Shim, Eunha
    Brown, Shawn T.
    DePasse, Jay
    Nowalk, Mary Patricia
    Raviotta, Jonathan M.
    Smith, Kenneth J.
    Zimmerman, Richard K.
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2016, 51 (03) : 309 - 317
  • [9] Do parents prefer inactivated or live attenuated influenza vaccine for their children?
    Santibanez, Tammy A.
    Kahn, Katherine E.
    Bridges, Carolyn B.
    VACCINE, 2018, 36 (48) : 7300 - 7305
  • [10] Understanding Immunity in Children Vaccinated With Live Attenuated Influenza Vaccine
    Shannon, Ian
    White, Chantelle L.
    Nayak, Jennifer L.
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2020, 9 : S10 - S14